Contact
RESOURCES
Global Point of Care
About Abbott

TOXICOLOGY

Quantisal™ Oral Fluid Collection Devices

Contact Us
Quantisal™ Oral Fluid Collection Device

Quantisal™ collection devices are widely used for oral fluid drug testing, combining unique scientific advantages with the efficiency of a simple, convenient specimen collection. Quantisal offers an innovative testing format that allows samples to be collected anytime, anywhere.

Benefits
icon
Collect samples anywhere, protecting against specimen tampering or adulteration
icon
Excellent indication of recent drug use with parent drugs present in higher concentration than metabolites
icon
Non-invasive, gender-neutral specimen collections
Quantisal™ Oral Fluid Collection Device

Quantisal™ Oral Fluid Collection Device

The Quantisal™ Oral Fluid Collection Device is widely used for oral fluid drug testing in workplace or pain and addiction practice settings. It allows for a simple noninvasive observed collection to avoid issues with sample adulteration or donor privacy.​

Features:​

  • Collects 1 mL +10% oral fluid​
  • Excellent indication of recent drug use1​
  • Excellent extraction efficiencies​
  • No artificial stimulants​
  • Volume adequacy indicator​
  • Reduces specimen adulteration​
Learn More
Quantisal™ Oral Fluid Collection Device

Quantisal™ II Oral Fluid Split Specimen
Collection Device

Quantisal™ II is the first commercially available oral fluid device with split specimen capabilities, offering you the simplicity of collecting two samples with a single device that meets SAMHSA2 and DOT3 guidelines.

All the Features of Quantisal plus:​
  • Simultaneous collection of A and B specimens​
  • Proprietary FDA 510(k) cleared device​
Learn More
Helpful Documents

Product Documents

References

  1. White, R, Moore, C. Detection of Drugs and Their Metabolites in Oral Fluid. Elsevier and RTI International, 2018
  2. Substance Abuse and Mental Health Services Administration (SAMHSA)
  3. Department of Transportation (DOT), Federal Aviation Administration, 14 CFR Part 120, Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Oral Fluid Specimen Testing for Drugs, Federal Register Vol. 88 No. 84, May 02, 2023

A Leader in Toxicology

About Us
Our Solutions
Laboratory Drug Testing Services
Forensic Use Products
Products
Support
Interest-Based Ads
Contact Us
CONSUMER HEALTH DATA PRIVACY POLICY

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy and Cookie Policy. HIPAA & Patient Info

Abbott - A Global Leader in Toxicology.